Related by context. Frequent words. (Click for all words.) 69 Phase Ib clinical 67 phase IIb clinical 66 Phase 1b clinical 66 phase IIa 64 placebo controlled clinical 63 Phase 2a clinical 63 relapsed refractory multiple myeloma 62 dose escalation trial 62 SPIRIT IV 62 phase IIb 62 multicenter clinical 62 prospective multicenter 62 Phase Ia 62 Randomized controlled 62 randomized Phase III 62 Phase IIa clinical 62 elotuzumab 61 blinded placebo controlled 61 Phase IIb clinical 61 placebo controlled randomized 61 Phase III randomized 61 placebo controlled Phase 60 Phase 2b clinical 60 confirmatory Phase III 60 GLPG# 60 registrational trial 60 RRMS patients 60 OncoVEX GM CSF 60 IIa trial 59 tesmilifene 59 Phase III pivotal 59 Phase Ib 59 Phase IIa trial 59 randomized controlled clinical 59 confirmatory Phase 3 59 Phase 1b trial 59 Phase 2a trial 59 SPIRIT III 59 Phase III Clinical Trial 59 Phase 1b 59 active comparator 59 HGS ETR1 59 Phase 2b study 59 Phase III clinical 59 IIa clinical trial 58 multicentre 58 Azedra 58 phase 2a 58 Phase 2a 58 multicenter randomized 58 Phase 2b trial 58 Hepatitis C HCV 58 PRECiSE 58 prospective randomized controlled 58 registrational 58 Traficet EN 58 relapsed multiple myeloma 58 double blinded placebo 58 label multicenter 57 Pivotal Phase 57 Lu AA# 57 Amrubicin 57 metastatic hormone refractory 57 Completes Enrollment 57 Phase IIb trial 57 plus prednisone 57 Pivotal Phase III 57 Phase 1a 57 Cloretazine R VNP#M 57 multicenter randomized double 57 pertuzumab 57 hepatitis C HCV 57 Clinical Trial Results 57 Pivotal Trial 57 Mipomersen 57 custirsen 57 KNS # 57 deforolimus 57 ataluren 56 blind randomized controlled 56 Phase IIa 56 painful diabetic neuropathy 56 pharmacodynamic effects 56 pivotal Phase III 56 Diamyd ® 56 single ascending dose 56 axitinib 56 randomized controlled 56 KRN# 56 StemEx 56 Staccato loxapine 56 MyoCell 56 CCX# 56 safinamide 56 MEK inhibitor 56 Phase III 56 randomized clinical 56 dirucotide 56 Phase IIb 56 relapsing remitting multiple sclerosis 56 CR# vcMMAE